Upcoming Meetings: FDA's Orthopedic and Rehabilitation Devices Panel
This article was originally published in The Gray Sheet
Executive Summary
FDA's Orthopedic and Rehabilitation Devices Panel: Meeting on June 12 at 8:30 a.m. at the Holiday Inn in Gaithersburg, Maryland to discuss a premarket approval application for a total knee replacement device and clinical protocols for total hip replacement systems. FDA also will give a presentation on "conditions of approval and the gathering of long-term data." For more information call FDA's advisory committee information hotline: 800/741-8138 or 301/443-0572, or Paula Wilkerson at CDRH, 301/594-2036...
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.